Characterization of inpatient moyamoya in the United States: 1988-2004

Frontiers in Neurology

Volumn JUL, Issue , 2011, Pages

  Lee, Darrin J ^a   Liebeskind, David S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral ischemia; Collateral; Moyamoya; Stroke

Indexed keywords

EID: 84862871987     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2011.00043     Document Type: Article

References (20)

1. Baba, T., Houkin, K., and Kuroda, S. (2008). Novel epidemiological features of moyamoya disease. J. Neurol. Neurosurg. Psychiatr. 79, 900-904.
2. Bruno, A., Adams, H. P. Jr., Biller, J., Rezai, K., Cornell, S., and Aschenbrener, C. A. (1988). Cerebral infarction due to moyamoya disease in young adults. Stroke 19, 826-833.
3. Burke, G. M., Burke, A. M., Sherma, A. K., Hurley, M. C., Batjer, H. H., and Bendok, B. R. (2009). Moy-amoya disease: a summary. Neuro-surg. Focus 26, E11.
4. Chiu, D., Shedden, P., Bratina, P., and Grotta, J. C. (1998). Clinical features of moyamoya disease in the United States. Stroke 29, 1347-1351.
5. Cloft, H. J., Kallmes, D. F., Snider, R., and Jensen, M. E. (1999). Idiopathic supraclinoid and internal carotid bifurcation steno-occlusive disease in young American adults. Neurora-diology 41, 772-776.
6. Edwards-Brown, M. K., and Quets, J. P. (1997). Midwest experience with moyamoya disease. Clin. Neurol. Neurosurg. 99(Suppl. 2), S36-S38.
7. Gebreyohanns, M., and Adams, R. J. (2004). Sickle cell disease: primary stroke prevention. CNS Spectr. 9, 445-449.
8. Goldstein, L. B. (1998). Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke 29, 1602-1604.
9. Goto, Y., and Yonekawa, Y. (1992). Worldwide distribution of moy-amoya disease. Neurol. Med. Chir. (Tokyo) 32, 883-886.
10. Graham, J. F., and Matoba, A. (1997). A survey of moyamoya disease in Hawaii. Clin. Neurol. Neurosurg. 99(Suppl. 2), S31-S35.
11. Hallemeier, C. L., Rich, K. M., Grubb, R. L. Jr., Chicoine, M. R., Moran, C.J., Cross, D. T. III, Zipfel, G. J., Dacey, R. G. Jr., and Derdeyn, C. P. (2006). Clinical features and out come in North American adults with moyamoya phenomenon. Stroke 37, 1490-1496.
12. Mesiwala, A. H., Sviri, G., Fatemi, N., Britz, G. W., and Newell, D.W. (2008). Long-term out come of superficial temporal artery- middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg. Focus 24, E15.
13. Numaguchi, Y., Gonzalez, C. F., Davis, P. C., Monajati, A., Afshani, E., Chang, J., Sutton, C. L., Lee, R. R., and Shibata, D. K. (1997). Moyamoya disease in the United States. Clin. Neurol. Neurosurg. 99(Suppl. 2), S26-S30.
14. Pegelow, C. H. (2001). Stroke in children with sickle cell anaemia: aetiology and treatment. Paediatr. Drugs 3, 421-432.
15. Riebel, T., Kebelmann-Betzing, C., Gotze, R., and Overberg, U. S. (2003). Transcranial Doppler ultrasonography in neurologically asymptomatic children and young adults with sickle cell disease. Eur. Radiol. 13, 563-570.
16. Scott, R. M., and Smith, E. R. (2009). Moyamoya disease and moyamoya syndrome. N. Engl. J. Med. 360, 1226-1237.
17. Scott, R. M., Smith, J. L., Robertson, R. L., Madsen, J. R., Soriano, S. G., and Rockoff, M. A. (2004). Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J. Neurosurg. 100, 142-149.
18. Takeuchi, K., and Shimizu, K. (1957). Hypoplasia of the bilateral internal carotid arteries. Brain Nerve 9, 37-43.
19. Uchino, K., Johnston, S. C., Becker, K. J., and Tirschwell, D. L. (2005). Moyamoya disease in Washington State and California. Neurology 65, 956-958.
20. Yilmaz, E. Y., Pritz, M. B., Bruno, A., Lopez-Yunez, A., and Biller, J. (2001). Moyamoya: Indiana University Medical Center experience. Arch. Neurol. 58, 1274-1278.